BELANO Medical - The Micro­biotics Company
BELANO Medical
The Micro­biotics Company

Press releases

New Hand Care Product and New Remedy for Itching Scalps 

Hydro gel regene­rates skin flora even if hands are disin­fected to avoid Corona - New products speci­fi­cally intended for hand care and scalp care, as well as other hairy parts of the body, have been added to the “ibiotics med” range of medical skincare. BELANO medical AG developed a micro­biotic hand hydrogel and a micro­biotic hand cream. Both may help in recovering a healthy skin

New Hand Care Product and New Remedy for Itching Scalps mehr lesen

read more 

BELANO medical Boosts Distribution of Microbiome Products 

BELANO medical AG will team up with b.value AG, headquar­tered in Düsseldorf, and Deutsche Biotech Innovativ AG (DBI), which is based in Hennigsdorf bei Berlin, in the future develo­pment and distri­bution of micro­bio­lo­gical and microbial ingre­dients for medical products and micro­biome products. As part of this agreement, both companies have acquired shares in BELANO medical. read full press release

BELANO medical Boosts Distri­bution of Micro­biome Products mehr lesen

read more 

Antibiotics-Free Relief for Strep Throat Infections 

New micro­biotic agent also prevents super-infec­­tions Hennigsdorf b. Berlin, 29 July 2020 – “salvans® throat pastilles”, the world’s first micro­biotic antibac­terial lozenges, will be available for sale from 1 August. Intended for use against bacterial throat infec­tions and inflamma­tions of the pharynx, as well as the prevention of secondary infec­tions, this medical product contains the micro­biotic agent salvans® and marsh­mallow root extract. read more

Antibiotics-Free Relief for Strep Throat Infec­tions mehr lesen

read more 

Novel bioactive from Lactobacillus brevis DSM17250 to stimulate the growth of Staphylococcus epidermidis: a pilot study 

Commensal skin micro­biota plays an important role in both influ­encing the immune response of the skin and acting as a barrier against coloni­sation of poten­tially patho­genic micro­or­ga­nisms and overgrowth of oppor­tu­nistic pathogens. Staphy­lo­coccus epider­midis is a key consti­tuent of the normal micro­biota on human skin. It balances the inflammatory response after skin injury and produces antimi­crobial molecules that selec­tively inhibit skin pathogens. C. Holz,

Novel bioactive from Lacto­ba­c­illus brevis DSM17250 to stimulate the growth of Staphy­lo­coccus epider­midis: a pilot study mehr lesen

read more 

European Biotechnology - The problem starts in your gut 

Evidence that what we eat and how we live affects our health is becoming greater.The bacteria, who have been colonising our skin and gut since our very beginning, seem to play an important role as sensors for environ­mental triggers of chronic diseases of civili­sation. Since it became clear that restoring the balance of the micro­biome cures 90% of people with Clostridium dificile infec­tions, food

European Biotech­nology - The problem starts in your gut mehr lesen

read more 
Scroll to Top